130 related articles for article (PubMed ID: 20644096)
1. Early warning: an ailing canary in the mine.
Dilts DM
J Clin Oncol; 2010 Aug; 28(24):3799-800. PubMed ID: 20644096
[No Abstract] [Full Text] [Related]
2. Researchers left to guess at outcomes of most cancer clinical trials.
Twombly R
J Natl Cancer Inst; 2009 Jan; 101(2):72-4. PubMed ID: 19141774
[No Abstract] [Full Text] [Related]
3. Leaders worry that U.S. is losing edge on cancer clinical trials.
Twombly R
J Natl Cancer Inst; 2008 Sep; 100(17):1196-9. PubMed ID: 18728275
[No Abstract] [Full Text] [Related]
4. Barriers to clinical trial enrollment: are state mandates the solution?
Hillner BE
J Natl Cancer Inst; 2004 Jul; 96(14):1048-9. PubMed ID: 15265958
[No Abstract] [Full Text] [Related]
5. Time to activate lung cancer clinical trials and patient enrollment: a representative comparison study between two academic centers across the atlantic.
Wang-Gillam A; Williams K; Novello S; Gao F; Scagliotti GV; Govindan R
J Clin Oncol; 2010 Aug; 28(24):3803-7. PubMed ID: 20644091
[TBL] [Abstract][Full Text] [Related]
6. The challenges of clinical trials for adolescents and young adults with cancer.
Ferrari A; Montello M; Budd T; Bleyer A
Pediatr Blood Cancer; 2008 May; 50(5 Suppl):1101-4. PubMed ID: 18360838
[TBL] [Abstract][Full Text] [Related]
7. Medicine. A bruising battle over lung scans.
Marshall E
Science; 2008 May; 320(5876):600-3. PubMed ID: 18451275
[No Abstract] [Full Text] [Related]
8. Awards bridge 'valley of death'.
Dorey E
Nat Biotechnol; 2009 Aug; 27(8):678. PubMed ID: 19668154
[No Abstract] [Full Text] [Related]
9. Strengthening accrual to cancer clinical trials.
Trimble EL; Denicoff AM; Abrams JS
Gynecol Oncol; 2010 Mar; 116(3):291-2. PubMed ID: 20152512
[No Abstract] [Full Text] [Related]
10. Modernizing Clinical Trials for Patients With Cancer.
Sharpless NE; Doroshow JH
JAMA; 2019 Feb; 321(5):447-448. PubMed ID: 30673081
[No Abstract] [Full Text] [Related]
11. Japan works to shorten "drug lag," boost trials of new drugs.
Sinha G
J Natl Cancer Inst; 2010 Feb; 102(3):148-51. PubMed ID: 20107160
[No Abstract] [Full Text] [Related]
12. Cooperative groups say NCI trials funding inadequate; some turn to industry.
Schmidt C
J Natl Cancer Inst; 2007 Jun; 99(11):830-1, 837. PubMed ID: 17551138
[No Abstract] [Full Text] [Related]
13. Drug shortages delay cancer clinical trials.
Goozner M
J Natl Cancer Inst; 2012 Jun; 104(12):891-2. PubMed ID: 22715189
[No Abstract] [Full Text] [Related]
14. Advisors may urge NIH to seek out industry support for clinical trials.
Appel A
Nature; 1995 Nov; 378(6553):116. PubMed ID: 7477301
[No Abstract] [Full Text] [Related]
15. StatBite: Stimulus funding: where does the NCI propose to invest?
J Natl Cancer Inst; 2009 Sep; 101(17):1169. PubMed ID: 19679852
[No Abstract] [Full Text] [Related]
16. The National Cancer Institute and its Director: worthy of our full support.
Chabner BA
Oncologist; 2009 Feb; 14(2):108-9. PubMed ID: 19147687
[No Abstract] [Full Text] [Related]
17. Managing coverage for clinical trials.
Newcomer LN
Eff Clin Pract; 1999; 2(5):244-6. PubMed ID: 10623058
[No Abstract] [Full Text] [Related]
18. National Cancer Institute helps businesses cross 'the valley of death'.
Nair P
Nat Med; 2008 Aug; 14(8):795. PubMed ID: 18685581
[No Abstract] [Full Text] [Related]
19. Re: Clinical trials registration efforts gain some ground.
Manrow RE
J Natl Cancer Inst; 2005 Jun; 97(12):936. PubMed ID: 15956658
[No Abstract] [Full Text] [Related]
20. AIDS research. Drug trials without the drugs?
Cohen J
Science; 2003 May; 300(5623):1212-3. PubMed ID: 12764159
[No Abstract] [Full Text] [Related]
[Next] [New Search]
